Literature DB >> 12471108

Cross-regulation of T cell growth factor expression by p53 and the Tax oncogene.

Sohail Chaudhry1, Wendy J Freebern, James L Smith, Wayne G Butscher, Cynthia M Haggerty, Kevin Gardner.   

Abstract

In this study, we demonstrate that p53 directly inhibits expression of the T cell growth factor (IL-2) in activated T cells. This repression is independent of the intrinsic transcriptional activity of p53 and is mediated by the Tax-responsive CD28RE-3'-12-O-tetradecanoylphorbol-13-acetate response element (AP1) element of the IL-2 promoter. Coexpression of the Tax oncogene causes full reversal of this repression through coordinate targeting of p300, CREB, and the NF-kappaB pathways. Paradoxically, IL-2 repression by p53 is not reversed by mdm2. Instead, mdm2 represses the IL-2 promoter by a mechanism that is synergistic with p53 and resistant to Tax reversal. The p300 structure-function studies show that these effects are linked to competitive associations among p53, Tax, and mdm2 with multiple domains of p300. The functional outcome of these antagonistic associations is revealed further by the observation that Tax and p53 induce apoptosis in activated T cells through separate and mutually exclusive pathways. Interestingly, both pathways are abrogated by mdm2. These results provide evidence that a dynamic interplay, between Tax and specific elements of the p53 network, mediates growth factor expression and programmed cell death in activated T cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471108     DOI: 10.4049/jimmunol.169.12.6767

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Kinetic profiles of p300 occupancy in vivo predict common features of promoter structure and coactivator recruitment.

Authors:  James L Smith; Wendy J Freebern; Irene Collins; Adriana De Siervi; Idalia Montano; Cynthia M Haggerty; Markey C McNutt; Wayne G Butscher; Inna Dzekunova; David W Petersen; Ernest Kawasaki; Juanita L Merchant; Kevin Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-30       Impact factor: 11.205

2.  The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome.

Authors:  Alexandra Oteiza; Nadir Mechti
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

Review 3.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

4.  The tumour suppressor gene p53 modulates the severity of antigen-induced arthritis and the systemic immune response.

Authors:  M Leech; J R Xue; A Dacumos; P Hall; L Santos; Y Yang; M Li; A R Kitching; E F Morand
Journal:  Clin Exp Immunol       Date:  2008-03-12       Impact factor: 4.330

5.  Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.

Authors:  Chul Won Lee; Munehito Arai; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Biochemistry       Date:  2009-03-17       Impact factor: 3.162

6.  Transcriptional autoregulation by BRCA1.

Authors:  Adriana De Siervi; Paola De Luca; Jung S Byun; Li Jun Di; Temesgen Fufa; Cynthia M Haggerty; Elba Vazquez; Cristian Moiola; Dan L Longo; Kevin Gardner
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

7.  Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40.

Authors:  Wanda Niedbala; Beilei Cai; Haiying Liu; Nick Pitman; Lynda Chang; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-17       Impact factor: 11.205

Review 8.  Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy.

Authors:  Yong Liu; Patrick L Leslie; Yanping Zhang
Journal:  Trends Cancer       Date:  2020-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.